Author: admin

Unlock the Editor’s Digest for free

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.

Pick your poison: beer or cigarettes? Weak share prices are pushing cash yields on the biggest brewers closer to those of sin-bin stalwart, Big Tobacco. For investors with the bottle for a sector that seems to be sliding into pariah territory, that could spell opportunity. 

Recent news has contributed to investors’ sour mood. Shares in AB InBev, the world’s largest brewer and maker of Budweiser and Stella Artois beers, fell on Thursday despite an unexpectedly generous $6bn two-year share buyback. Numbers two and three, Heineken and Carlsberg, recently reported falls in quantity sold, and stuck with already-watered down profit forecasts.  

Over the past year, only shares in Carlsberg are in the black — and then, only barely. Its heftier rivals are each down roughly a tenth. Volumes have become a key metric for investors as brewers try to offset mature western markets with growth in less developed countries and in newer categories such as alcohol-free beer.

But key growth spots have gone flat, with Brazil hurt by bad weather and economic uncertainty — a factor in China too, which also this year banned alcohol from official events. Consumption in Vietnam, a market prized for its large, young population, has been slow to recover from the impact of a strict 2020 drink-driving law. 

Mega-brewers’ relegation from the premium to the bargain shelves has been a long process. From trading on at least 20 times expected earnings in 2020, the three brewers now trade on between 12 and 14 times 2026 forecasts. Investors appear to fear that consumption will flag under the influence of public health groups and a more alcohol-conscious younger generation. 

Investors gloomily peering into their half-empty glasses could choose to see things differently. Granted, neither Big Beer’s top nor bottom line have been effervescent of late. But managers have used a mix of price rises and cost cuts to boost free cash flow. AB Inbev, whose annual cash generation after investments is 9 per cent of its market capitalisation, is not far short of the 12 per cent yielded by tobacco stocks — a sector that has handsomely rewarded investors prepared to accept its sinful status.

Big Beer, for all its doubters, isn’t Big Tobacco. It still has growth potential if key markets steady. In the meantime, cash is a good consolation.

jennifer.hughes@ft.com

Stay informed with free updates

Simply sign up to the Retail & Consumer industry myFT Digest — delivered directly to your inbox.

Boots is being sued by a travel accessories company that claims travel pillows sold by the UK retailer imitate its “particularly ergonomic” design and breach its intellectual property rights.

Travel Blue has launched a lawsuit against Boots at the High Court in London, demanding the beauty and health retailer stop infringing its design. It has called for unquantified damages and wants Boots to destroy or hand over unsold pillows.

U-shaped pillows have existed since at least the 1920s, when Elizabeth Millson of New York patented one in the US for use in baths.

Together with noise-cancelling headphones, the modern version has become a fixture of long-haul economy class flights. The neck-supporting products offer a degree of comfort — and the promise of sleep — to passengers confronted with limited leg room and barely reclining seats.

Travel Blue’s lawsuit, which was filed in September, recognises that all travel pillows need to “fit around a person’s neck, to provide support for that person’s neck whilst travelling and to be transportable”.

However, the legal claim states that specific elements of some pillows sold by Boots mean they infringe on a design that Travel Blue has registered with the UK’s Intellectual Property Office.

Nicholas Caddick KC, representing the UK accessories company, said in court papers that Travel Blue’s design had “significant features” that created an “overall impression of a particularly ergonomic and comfortable travel pillow with flowing rather than rigid lines”.

He set out a range of similarities between Travel Blue’s design and Boots’, including legs that had “a bulbous appearance accentuating the support” to the sides of the user’s head.

Caddick continued: “When viewed from the rear, an undulating top profile with a concave centre section flanked by raised lateral support points, once again, giving the appearance of enhanced support for the wearer’s head and neck”.

A Boots spokesperson said “We don’t believe the claim has any merit and will be strongly defending our position.” According to court records the company has retained law firm Browne Jacobson to defend it in the case. Defence documents have yet to be filed with the court.

Boots operates stores in several UK airports among about 1,800 stores, selling travel essentials and health and beauty products.

The chain, formerly part of US-listed Walgreens Boots Alliance, became a standalone entity this year after private equity group Sycamore Partners took WBA private and split off the international health and beauty retailer and drug wholesaling business as The Boots Group.

Travel Blue, founded in 1987, is a family-owned business and sells its products through a wide range of airport duty free outlets as well as luggage and bag shops and department stores around the world, as well as online.

Story Continues